Ezetimibe Nitroso Impurity 2
 
		Product Description
CAT No.
				
									ALN-E026102								
				CAS No.
				
									NA								
				Mol. F.
				
									C24H22F2N2O4								
				Mol. Wt.
				
									440.4								
				Stock
				
									Please Inquire								
				
										
							
										Product Overview
						
											
										
							
										Technical Data
						
											
										
							
										Reference
						
											
										
							
										RFQ
						
									
							
							
							Product Overview
			
						
									Chemical Name : (2R,5S)-N,5-Bis(4-fluorophenyl)-5-hydroxy-2-((4-hydroxycyclohexa-2,5-dien-1-ylidene)methyl)-N-nitrosopentanamide								
				
									Smiles : FC1=CC=C([C@@H](O)CC[C@H](/C=C2C=CC(O)C=C/2)C(N(N=O)C3=CC=C(F)C=C3)=O)C=C1								
				
							
							
							Technical Data
			
						
							
							
							Reference
			
						Related substances by HPLC method for the detection and evaluation of impurities in ezetimibe drug material
									By Rapeti, Durgababu; Reddy, Gudibanda Chandra Sekhar; Narayanarao, Kapavarapu Maruthi Venkata; Shyamala, Pulipaka; Krishna, Rallabhandi MuralinFrom International Journal of Pharmaceutical Sciences and Research (2021), 12(1), 217-225								
				Stability-indicating liquid chromatographic method for the simultaneous determination of rosuvastatin and ezetimibe from pharmaceuticals and biological samples
									By Kurbanoglu, Sevinc; Esim, Ozgur; Ozkan, Cansel Kose; Savaser, Ayhan; Ozkan, Yalcin; Uslu, Bengi; Ozkan, Sibel A. – From Journal of the Turkish Chemical Society, Section A: Chemistry (2020), 7(3), 865-874 								
				Stability-indicating analytical method development using quality by design approach for simultaneous estimation of ezetimibe and glimepiride
									By Shah, U.; Shah, Kunti; Patel, Rupal – From Indian Journal of Pharmaceutical Sciences (2019), 81(2), 273-281								
				
							
							
							RFQ
			
						
 
                             
                             
                             
                             
                            